SEC Form 4 · accession 0000899243-15-003607
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard K Prins
Director
Period of report
Aug 17, 2015
Accepted (ET)
Aug 19, 2015 · 8:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 17, 2015 | M | 5,400 | $10.77 | A | 48,122 | D | |
| Common StockF1 | Aug 17, 2015 | S | 5,400 | $14.7008 | D | 42,722 | D | |
| Common Stock | Aug 18, 2015 | M | 2,100 | $10.77 | A | 44,822 | D | |
| Common StockF2 | Aug 18, 2015 | S | 9,100 | $14.6588 | D | 35,722 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $10.77 | Aug 17, 2015 | M | 5,400 | D | — | Dec 15, 2017 | Common Stock | 5,400 | 42,100 | D |
| Stock Option (right to buy)F3 | $10.77 | Aug 18, 2015 | M | 2,100 | D | — | Dec 15, 2017 | Common Stock | 2,100 | 40,000 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.5625 to $14.805, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.52 to $14.885, inclusive.
- F3Shares subject to the option are fully vested and immediately exercisable.